Literature DB >> 15459695

How I became one of the fathers of a superfamily.

Pierre Chambon1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15459695     DOI: 10.1038/nm1004-1027

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  One hundred years of hormones.

Authors:  Jamshed R Tata
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

Review 2.  Twenty years of nuclear receptors: Conference on Nuclear Receptors: from Chromatin to Disease.

Authors:  Laszlo Nagy; Roland Schüle; Hinrich Gronemeyer
Journal:  EMBO Rep       Date:  2006-05-26       Impact factor: 8.807

3.  CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen.

Authors:  Yu Zhang; Jing Liang; Yanyan Li; Chenghao Xuan; Feng Wang; Dandan Wang; Lei Shi; Di Zhang; Yongfeng Shang
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

Review 4.  Crosstalk between nuclear and G protein-coupled estrogen receptors.

Authors:  Shannon N Romano; Daniel A Gorelick
Journal:  Gen Comp Endocrinol       Date:  2017-04-25       Impact factor: 2.822

Review 5.  Macrophage ontogeny in the control of adipose tissue biology.

Authors:  Nehemiah Cox; Frederic Geissmann
Journal:  Curr Opin Immunol       Date:  2019-10-26       Impact factor: 7.486

6.  Looking for the mechanism of action of thyroid hormone.

Authors:  Jamshed R Tata
Journal:  J Thyroid Res       Date:  2011-07-24

Review 7.  Transcriptional Factors Mediating Retinoic Acid Signals in the Control of Energy Metabolism.

Authors:  Rui Zhang; Yueqiao Wang; Rui Li; Guoxun Chen
Journal:  Int J Mol Sci       Date:  2015-06-23       Impact factor: 5.923

8.  Tamoxifen suppresses pancreatic β-cell proliferation in mice.

Authors:  Surl-Hee Ahn; Anne Granger; Matthew M Rankin; Carol J Lam; Aaron R Cox; Jake A Kushner
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.